SEC Form 4 · accession 0001161697-17-000391
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J McEnany
Officer — President and CEO · Director
Period of report
Sep 5, 2017
Accepted (ET)
Sep 5, 2017 · 11:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Sep 5, 2017 | P | 20,000 | $2.578 | A | 4,471,026 | D |
Table II — derivative securities
No Table II lines on this filing.